Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue

W. Yuan, B. Liu, M. Sanda, R. Wei, J. Benicky, Z. Novakova, C. Barinka, R. Goldman

. 2022 ; 82 (1) : 132-144. [pub] 20211018

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011588

Grantová podpora
P30 CA051008 NCI NIH HHS - United States
S10 OD023557 NIH HHS - United States
U01 CA230692 NCI NIH HHS - United States

INTRODUCTION: N-glycosylation is a ubiquitous and variable posttranslational modification that regulates physiological functions of secretory and membrane-associated proteins and the dysregulation of glycosylation pathways is often associated with cancer growth and metastasis. Prostate-specific membrane antigen (PSMA) is an established biomarker for prostate cancer imaging and therapy. METHODS: Mass spectrometry was used to analyze the distribution of the site-specific glycoforms of PSMA in insect, human embryonic kidney, and prostate cancer cells, and in prostate tissue upon immunoaffinity enrichment. RESULTS: While recombinant PSMA expressed in insect cells was decorated mainly by paucimannose and high mannose glycans, complex, hybrid, and high mannose glycans were detected in samples from human cells and tissue. We noted an interesting spatial distribution of the glycoforms on the PSMA surface-high mannose glycans were the dominant glycoforms at the N459, N476, and N638 sequons facing the plasma membrane, while the N121, N195, and N336 sites, located at the exposed apical PSMA domain, carried primarily complex glycans. The presence of high mannose glycoforms at the former sequons likely results from the limited access of enzymes of the glycosynthetic pathway required for the synthesis of the complex structures. In line with the limited accessibility of membrane-proximal sites, no glycosylation was observed at the N51 site positioned closest to the membrane. CONCLUSIONS: Our study presents initial descriptive analysis of the glycoforms of PSMA observed in cell lines and in prostate tissue. It will hopefully stimulate further research into PSMA glycoforms in the context of tumor staging, noninvasive detection of prostate tumors, and the impact of glycoforms on physicochemical and enzymatic characteristics of PSMA in a tissue-specific manner.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011588
003      
CZ-PrNML
005      
20220506130551.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/pros.24254 $2 doi
035    __
$a (PubMed)34662441
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Yuan, Wei $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA $u Clinical and Translational Glycoscience Research Center, Georgetown University Medical Center, Georgetown University, Washington DC, USA
245    10
$a Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue / $c W. Yuan, B. Liu, M. Sanda, R. Wei, J. Benicky, Z. Novakova, C. Barinka, R. Goldman
520    9_
$a INTRODUCTION: N-glycosylation is a ubiquitous and variable posttranslational modification that regulates physiological functions of secretory and membrane-associated proteins and the dysregulation of glycosylation pathways is often associated with cancer growth and metastasis. Prostate-specific membrane antigen (PSMA) is an established biomarker for prostate cancer imaging and therapy. METHODS: Mass spectrometry was used to analyze the distribution of the site-specific glycoforms of PSMA in insect, human embryonic kidney, and prostate cancer cells, and in prostate tissue upon immunoaffinity enrichment. RESULTS: While recombinant PSMA expressed in insect cells was decorated mainly by paucimannose and high mannose glycans, complex, hybrid, and high mannose glycans were detected in samples from human cells and tissue. We noted an interesting spatial distribution of the glycoforms on the PSMA surface-high mannose glycans were the dominant glycoforms at the N459, N476, and N638 sequons facing the plasma membrane, while the N121, N195, and N336 sites, located at the exposed apical PSMA domain, carried primarily complex glycans. The presence of high mannose glycoforms at the former sequons likely results from the limited access of enzymes of the glycosynthetic pathway required for the synthesis of the complex structures. In line with the limited accessibility of membrane-proximal sites, no glycosylation was observed at the N51 site positioned closest to the membrane. CONCLUSIONS: Our study presents initial descriptive analysis of the glycoforms of PSMA observed in cell lines and in prostate tissue. It will hopefully stimulate further research into PSMA glycoforms in the context of tumor staging, noninvasive detection of prostate tumors, and the impact of glycoforms on physicochemical and enzymatic characteristics of PSMA in a tissue-specific manner.
650    _2
$a antigeny povrchové $x metabolismus $7 D000954
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a buněčné linie $7 D002460
650    _2
$a glutamátkarboxypeptidasa II $x metabolismus $7 D043425
650    _2
$a glykosylace $7 D006031
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a hmotnostní spektrometrie $x metody $7 D013058
650    _2
$a staging nádorů $7 D009367
650    12
$a polysacharidy $x klasifikace $x metabolismus $7 D011134
650    12
$a prostata $x enzymologie $x metabolismus $x patologie $7 D011467
650    12
$a nádory prostaty $x metabolismus $x patologie $7 D011471
650    _2
$a posttranslační úpravy proteinů $7 D011499
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Liu, Baoqin $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA
700    1_
$a Sanda, Miloslav $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA $u Clinical and Translational Glycoscience Research Center, Georgetown University Medical Center, Georgetown University, Washington DC, USA
700    1_
$a Wei, Renhuizi $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA $u Clinical and Translational Glycoscience Research Center, Georgetown University Medical Center, Georgetown University, Washington DC, USA
700    1_
$a Benicky, Julius $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA $u Clinical and Translational Glycoscience Research Center, Georgetown University Medical Center, Georgetown University, Washington DC, USA
700    1_
$a Novakova, Zora $u Laboratory of Structural Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic $1 https://orcid.org/0000000198046346
700    1_
$a Barinka, Cyril $u Laboratory of Structural Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic $1 https://orcid.org/0000000327513060 $7 xx0126049
700    1_
$a Goldman, Radoslav $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA $u Clinical and Translational Glycoscience Research Center, Georgetown University Medical Center, Georgetown University, Washington DC, USA $u Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington DC, USA
773    0_
$w MED00010484 $t The Prostate $x 1097-0045 $g Roč. 82, č. 1 (2022), s. 132-144
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34662441 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130543 $b ABA008
999    __
$a ok $b bmc $g 1789274 $s 1162786
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 82 $c 1 $d 132-144 $e 20211018 $i 1097-0045 $m The Prostate $n Prostate $x MED00010484
GRA    __
$a P30 CA051008 $p NCI NIH HHS $2 United States
GRA    __
$a S10 OD023557 $p NIH HHS $2 United States
GRA    __
$a U01 CA230692 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace